Capital International Inc. CA Purchases 20,636 Shares of Humana Inc. $HUM

Capital International Inc. CA lifted its position in Humana Inc. (NYSE:HUM) by 68.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 50,930 shares of the insurance provider’s stock after acquiring an additional 20,636 shares during the period. Capital International Inc. CA’s holdings in Humana were worth $13,045,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Humana by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after acquiring an additional 106,030 shares in the last quarter. Capital International Investors increased its position in Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Humana by 28.9% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares in the last quarter. Pzena Investment Management LLC increased its position in Humana by 1.0% during the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock valued at $1,043,015,000 after buying an additional 41,125 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in Humana by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock valued at $812,540,000 after buying an additional 23,732 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on HUM shares. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 price objective on shares of Humana in a research report on Wednesday. Wolfe Research raised Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday. Bank of America raised their price objective on Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a research report on Thursday. Leerink Partners raised their price objective on Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research report on Thursday, April 30th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, Humana has an average rating of “Hold” and an average target price of $279.30.

Humana Stock Down 0.1%

Humana stock opened at $349.85 on Monday. The firm has a market cap of $42.00 billion, a price-to-earnings ratio of 37.42, a PEG ratio of 2.00 and a beta of 0.76. The stock has a fifty day simple moving average of $248.43 and a two-hundred day simple moving average of $232.39. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $351.88. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same quarter last year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts predict that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.